Drug release valve for a parenteral administration system
Latest Aktiebolaget Hassle Patents:
- Therapeutically active fluoro substituted benzimidazoles
- Therapeutically active fluoro substituted benzimidazoles
- Particle having a dyed coke indicator and a pharmaceutical coating for parenteral administration of the pharmaceutical
- Drug preparation
- Certain pyridyl[(methylthio- or methyl sulfinyl)-2 benzimidazol-2-yl]N-methyl phosphonates useful for treating gastric-acid secretion related diseases
Description
FIG. 1 is a front elevational view of a drug release valve for a parenteral administration system, showing our new design;
FIG. 2 is a front elevational view thereof;
FIG. 3 is a side elevational view thereof, the opposite side being identical thereto;
FIG. 4 is a front elevational view thereof, with the cartridge portion removed;
FIG. 5 is a side elevational view of the cartridge portion;
FIG. 6 is a rear elevational view thereof;
FIG. 7 is a side elevational view thereof, opposite that shown in FIG. 5;
FIG. 8 is a rear elevational view of the drug release valve; and
FIG. 9 is an end elevational view thereof, opposite the spike end.
Referenced Cited
Patent History
Patent number: D314051
Type: Grant
Filed: Jan 7, 1987
Date of Patent: Jan 22, 1991
Assignee: Aktiebolaget Hassle (Molndal)
Inventors: Bengt G. Berglund (Goteborg), Nils B. Nilson (Mjolby), Ake S. Nilsson (Goteborg)
Primary Examiner: A. Hugo Word
Assistant Examiner: Stella M. Reid
Law Firm: White & Case
Application Number: 7/1,105
Type: Grant
Filed: Jan 7, 1987
Date of Patent: Jan 22, 1991
Assignee: Aktiebolaget Hassle (Molndal)
Inventors: Bengt G. Berglund (Goteborg), Nils B. Nilson (Mjolby), Ake S. Nilsson (Goteborg)
Primary Examiner: A. Hugo Word
Assistant Examiner: Stella M. Reid
Law Firm: White & Case
Application Number: 7/1,105
Classifications
Current U.S. Class:
D24/53;
D24/51